advisorsecurities master

IRDOpus Genetics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17224
Ticker
IRD
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-11-06
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
IRD

Detail

Enriched 2026-08-14 20:47

Market cap
$312,816,294.48
Shares outstanding (class)
82,565,835
Shares outstanding (weighted)
83,195,823
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
28
Location
DURHAM, NC
Description

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data